[1]
Adami, G. et al. 2020. Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life. Reumatismo. 72, 2 (Jul. 2020), 71–74. DOI:https://doi.org/10.4081/reumatismo.2020.1267.